Abstract
Over recent years, whilst it is taking increased time and cost to get a new drug to market, productivity is declining. It is critical for the survival of the pharmaceutical industry, to both improve efficiency of the drug discovery and development process and to increase success rates, with better predictivity from preclinical to clinical investigation (Kola. 2008). Imaging provides unique tools to improve efficiency and predictivity.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Atkinson AJ Jr, Colburn WA, DeGruttola VG, DeMets DL, Downing GJ, Hoth DF, Oates JA, Peck CC, Schooley RT, Spilker BA, Woodcock J, Zeger SL (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89–95
Beckmann N et al (2001) Pulmonary edema induced by allergen challenge in the rat: non-invasive assessment by magnetic resonance imaging. Magn Reson Med 45:88–95
Bell JP, Chevalier E, Tessier J, Bradley D, Mather ME, Young SS, Bahl AK, Escott KJ, Young A (2007) Use of magnetic resonance imaging (MRI) to track big endothelin-1-induced edema in the rat lung. Am J Respir Crit Care Med 175:A533
Bowyer J, Heapy CG, Flannelly JK, Waterton JC, Maciewicz RA (2009) Evaluation of a magnetic resonance biomarker of osteoarthritis disease progression: doxycycline slows tibial cartilage loss in the Dunkin Hartley guinea pig. Int J Exp Pathol 90:174–181
Bradley DP, Tessier JJ, Ashton SE, Waterton JC, Wilson Z, Worthington PL, Ryan AJ (2007) Correlation of MRI biomarkers with tumor necrosis in Hras5 tumor xenograft in athymic rats. Neoplasia 9:382–391
Erondu N et al (2006) Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults. Cell Metab 4:260–262
Evelhoch JL, LoRusso PM, He Z, DelProposto Z, Polin L, Corbett TH, Langmuir P, Wheeler C, Stone A, Leadbetter J, Ryan AJ, Blakey DC, Waterton JC (2004) Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126. Clin Cancer Res 10:3650–3657
Fong TM (2008) Development of anti-obesity agents: drugs that target neuropeptide and neurotransmitter systems. Expert Opin Investig Drugs 17:321–325
Keen H, Ricketts SA, Bales J, Shannon A, Logie A, Odedra R, Wedge SR, Guichard SM (2010) The mTOR kinase inhibitor AZD8055 modulates 18F-FDG uptake in vivo in the human glioma xenograft model U87-MG. In: Proceedings AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics, Boston, p A225
Kola I (2008) The state of innovation in drug development. Clin Pharmacol Ther 83:227–230
Hockings PD (2006) Magnetic resonance imaging in pharmaceutical safety assessment. In: Vogel HG, Hock FJ, Maas J, Mayer D (eds) Drug discovery and evaluation: safety and pharmacokinetic assays. Springer, Heidelberg, pp 385–393
Holt MP, Ju C (2006) Mechanisms of drug-induced liver injury. AAPS J 8:E48–E54
Hopkins AL, Groom CR (2002) Opinion: the druggable genome. Nat Rev Drug Discov 1:727–730
Hultin L, Hyberg G, von Mentzer B, Martinez V (2004) Effects of corticotropin releasing factor and urocortins on gastric emptying and motility in rats assessed by functional X-ray. In: XII European Symposium on Neurogastroenterology and Motility, Cambridge, UK, p T150
McIntyre DJ, Robinson SP, Howe FA, Griffiths JR, Ryan AJ, Blakey DC, Peers IS, Waterton JC (2004) Single dose of the antivascular agent, ZD6126 (N-acetylcolchinol-O-phosphate), reduces perfusion for at least 96 hours in the GH3 prolactinoma rat tumor model. Neoplasia 6:150–157
McLarty K, Cornelissen B, Cai Z, Scollard DA, Costantini DL, Done SJ, Reilly RM (2009) Micro-SPECT/CT with 111In-DTPA-Pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDAMB-361 HUMAN breast cancer xenografts. J Nucl Med 50:1340–1348
Olsson LE et al (2009) 1H and hyperpolarized 3He MR imaging of mouse with LPS-induced inflammation. J Magn Reson Imaging 29:977–981
Tessier JJ, Bowyer J, Brownrigg NJ, Peers IS, Westwood FR, Waterton JC, Maciewicz RA (2003) Characterisation of the guinea pig model of osteoarthritis by in vivo three-dimensional magnetic resonance imaging. Osteoarthritis Cartilage 11:845–853
Ulloa J et al (2010) Effects of a single intravenous dose of estradiol 17β-glucoronide on bile flow: assessment with gadoxetate DCEMRI. Proceedings ISMRM 18, 2593
Waterton JC, Middleton BJ, Pickford R, Allott CP, Checkley D, Keith RA (2000) Reduced animal use in efficacy testing in disease models with use of sequential experimental designs. Dev Anim Vet Sci 31:737–745
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ricketts, SA., Hockings, P.D., Waterton, J.C. (2011). Non-Invasive Imaging in the Pharmaceutical Industry. In: Kiessling, F., Pichler, B. (eds) Small Animal Imaging. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-12945-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-12945-2_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-12944-5
Online ISBN: 978-3-642-12945-2
eBook Packages: MedicineMedicine (R0)